» Articles » PMID: 30619736

Delineating WWOX Protein Interactome by Tandem Affinity Purification-Mass Spectrometry: Identification of Top Interactors and Key Metabolic Pathways Involved

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Jan 9
PMID 30619736
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

It has become clear from multiple studies that WWOX (WW domain-containing oxidoreductase) operates as a "non-classical" tumor suppressor of significant relevance in cancer progression. Additionally, WWOX has been recognized for its role in a much wider array of human pathologies including metabolic conditions and central nervous system related syndromes. A myriad of putative functional roles has been attributed to WWOX mostly through the identification of various binding proteins. However, the reality is that much remains to be learned on the key relevant functions of WWOX in the normal cell. Here we employed a Tandem Affinity Purification-Mass Spectrometry (TAP-MS) approach in order to better define direct WWOX protein interactors and by extension interaction with multiprotein complexes under physiological conditions on a proteomic scale. This work led to the identification of both well-known, but more importantly novel high confidence WWOX interactors, suggesting the involvement of WWOX in specific biological and molecular processes while delineating a comprehensive portrait of WWOX protein interactome. Of particular relevance is WWOX interaction with key proteins from the endoplasmic reticulum (ER), Golgi, late endosomes, protein transport, and lysosomes networks such as SEC23IP, SCAMP3, and VOPP1. These binding partners harbor specific PPXY motifs which directly interact with the amino-terminal WW1 domain of WWOX. Pathway analysis of WWOX interactors identified a significant enrichment of metabolic pathways associated with proteins, carbohydrates, and lipids breakdown. Thus, suggesting that WWOX likely plays relevant roles in glycolysis, fatty acid degradation and other pathways that converge primarily in Acetyl-CoA generation, a fundamental molecule not only as the entry point to the tricarboxylic acid (TCA) cycle for energy production, but also as the key building block for synthesis of lipids and amino acids. Our results provide a significant lead on subsets of protein partners and enzymatic complexes with which full-length WWOX protein interacts with in order to carry out its metabolic and other biological functions while also becoming a valuable resource for further mechanistic studies.

Citing Articles

Neuroimaging features of WOREE syndrome: a mini-review of the literature.

Battaglia L, Scorrano G, Spiaggia R, Basile A, Palmucci S, Foti P Front Pediatr. 2024; 11:1301166.

PMID: 38161429 PMC: 10757851. DOI: 10.3389/fped.2023.1301166.


LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer.

Kolat D, Kaluzinska-Kolat Z, Kosla K, Orzechowska M, Pluciennik E, Bednarek A Front Genet. 2023; 14:1214968.

PMID: 37519886 PMC: 10373930. DOI: 10.3389/fgene.2023.1214968.


Antineoplastic Nature of in Glioblastoma Is Mainly a Consequence of Reduced Cell Viability and Invasion.

Kaluzinska-Kolat Z, Kosla K, Kolat D, Pluciennik E, Bednarek A Biology (Basel). 2023; 12(3).

PMID: 36979157 PMC: 10045224. DOI: 10.3390/biology12030465.


WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12.

Hussain T, Sanchez K, Crayton J, Saha D, Jeter C, Lu Y Prog Neurobiol. 2023; 223:102425.

PMID: 36828035 PMC: 10835625. DOI: 10.1016/j.pneurobio.2023.102425.


WWOX and metabolic regulation in normal and pathological conditions.

Baryla I, Kosla K, Bednarek A J Mol Med (Berl). 2022; 100(12):1691-1702.

PMID: 36271927 PMC: 9691486. DOI: 10.1007/s00109-022-02265-5.


References
1.
Lu P, Zhou X, Shen M, Lu K . Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science. 1999; 283(5406):1325-8. DOI: 10.1126/science.283.5406.1325. View

2.
Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, Seraphin B . A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol. 1999; 17(10):1030-2. DOI: 10.1038/13732. View

3.
Bednarek A, Laflin K, Daniel R, Liao Q, Hawkins K, Aldaz C . WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000; 60(8):2140-5. View

4.
Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow J . Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet. 2000; 9(11):1651-63. DOI: 10.1093/hmg/9.11.1651. View

5.
Chang N, Pratt N, Heath J, Schultz L, Sleve D, Carey G . Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem. 2000; 276(5):3361-70. DOI: 10.1074/jbc.M007140200. View